Skip to content

NRXPW

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.01
+0.00%
Ask drillr

Latest reported

Last report date
May 15, 2026
EPS actual
-$0.04
EPS estimate
$0.21
Revenue actual
$1.1M
Revenue estimate
$19.4M

Track record

Trailing twelve quarters

EPS beats (12Q)
0
EPS misses (12Q)
5
EPS in line (12Q)
0
Avg surprise (4Q)
-647.5%
Revenue beats (12Q)
0
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
May 15, 2026$0.21-$0.04Miss -119.14%$1.1M
Mar 23, 2026$0.01-$0.04Miss -703.32%$998.0K
Nov 17, 2025-$0.02-$0.26Miss -1214.84%$242.0K
Aug 18, 2025-$0.15-$0.98Miss -552.89%
May 15, 2025-$0.28-$0.52Miss -84.98%$1.1M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026